Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LUIS CASAUBON

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1447225495
CMS profile
20091
Location
AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$120.24

6 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $120.24 6

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Nevro Corp. $52.41 2
Medtronic, Inc. $34.64 2
RECORDATI_RARE_DISEASES_INC. $18.99 1
Xeris Pharmaceuticals, Inc. $14.20 1

Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LUIS CASAUBON

NPI 1447225495 · CMS profile ID 20091

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1447225495?year=2021&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LUIS CASAUBON, NPI 1447225495, CMS profile ID 20091. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1447225495?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). LUIS CASAUBON, NPI 1447225495, CMS profile ID 20091. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1447225495?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
LUIS CASAUBON, NPI 1447225495, CMS profile ID 20091, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1447225495?year=2021&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

6 matching records · $120.24 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 6 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–6 of 6.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Medtronic, Inc. $23.1511/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827258349 CMS
RECORDATI_RARE_DISEASES_INC. $18.9911/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 831402221 CMS
Nevro Corp. $18.7009/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832295625 CMS
Nevro Corp. $33.7107/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832295589 CMS
Xeris Pharmaceuticals, Inc. $14.2005/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837415747 CMS
Medtronic, Inc. $11.4905/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815755849 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $17.84 1
PY2021 $120.24 6
PY2022 $75.60 4
PY2023 $271.82 14
PY2024 $436.66 18
PY2025 $588.22 24

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $244,802.34 43
PY2024 Principal investigator $270,911.58 97
PY2023 Principal investigator $213,259.54 161
PY2022 Principal investigator $530,223.08 203
PY2021 Principal investigator $866,406.89 1,203
PY2020 Recipient $7,732.50 3
PY2020 Principal investigator $630,563.16 449
PY2019 Principal investigator $775,897.49 183

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

1,203 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novo Nordisk AS $25.06 12/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810737213
Principal investigator 1 Novo Nordisk AS $25.06 12/23/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811581767
Principal investigator 1 Novo Nordisk AS $1,350.00 12/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730139
Principal investigator 1 Novo Nordisk AS $100.00 12/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730149
Principal investigator 1 Novo Nordisk AS $4,089.15 12/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846997
Principal investigator 1 Novo Nordisk AS $3,719.28 12/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810853715
Principal investigator 1 Novo Nordisk AS $2,659.52 12/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811339897
Principal investigator 1 Novo Nordisk AS $5,684.62 12/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371147
Principal investigator 1 Novo Nordisk AS $10,694.85 12/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825273
Principal investigator 1 Novo Nordisk AS $1,795.00 12/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825275
Principal investigator 1 Medtronic, Inc. $210.00 12/21/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 801002909
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068053
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068067
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068077
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068091
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068103
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068117
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068129
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068143
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068155
Principal investigator 1 Novo Nordisk AS $300.00 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068165
Principal investigator 1 Novo Nordisk AS $300.00 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068177
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068715
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068729
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068743
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068977
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068991
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069005
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069017
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069031
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069045
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069059
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069073
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069085
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069098
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336951
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336959
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336969
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336977
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336987
Principal investigator 1 Novo Nordisk AS $300.00 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336995
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339395
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339405
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339415
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339425
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339435
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339707
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339719
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339729
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339739
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339747
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339757
Principal investigator 1 Novo Nordisk AS $300.00 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811349357
Principal investigator 1 Novo Nordisk AS $2.97 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369835
Principal investigator 1 Novo Nordisk AS $25.06 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369843
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785857
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785859
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785861
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785863
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785865
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785867
Principal investigator 1 Novo Nordisk AS $300.00 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785869
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787209
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787211
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787213
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787257
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787259
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787261
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825063
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825065
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825067
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825069
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825071
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825073
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825075
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825077
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825079
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825081
Principal investigator 1 Novo Nordisk AS $300.00 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825083
Principal investigator 1 Novo Nordisk AS $300.00 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825085
Principal investigator 1 Novo Nordisk AS $300.00 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825087
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825257
Principal investigator 1 Novo Nordisk AS $49.90 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825259
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825261
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825263
Principal investigator 1 Novo Nordisk AS $32.50 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825265
Principal investigator 1 Novo Nordisk AS $300.00 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825267
Principal investigator 1 Novo Nordisk AS $297.00 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 833636211
Principal investigator 1 Novo Nordisk AS $297.00 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 833636213
Principal investigator 1 Novo Nordisk AS $297.00 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 833636215
Principal investigator 1 Novo Nordisk AS $297.00 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 833636217
Principal investigator 1 Novo Nordisk AS $594.00 12/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 833636219
Principal investigator 1 Medtronic, Inc. $1,077.00 12/18/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 801006439
Principal investigator 1 Novo Nordisk AS $25.06 12/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398401
Principal investigator 1 Medtronic, Inc. $8,094.00 12/10/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 801002907
Principal investigator 1 Medtronic, Inc. $42.00 12/10/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP332 NGS No dispute reported 06/30/2026 801005875
Principal investigator 1 Medtronic, Inc. $630.00 12/08/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 801002905
Principal investigator 1 Novo Nordisk AS $25.06 12/08/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398391
Principal investigator 1 Medtronic, Inc. $96.00 12/07/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 801002917
Principal investigator 1 Novo Nordisk AS $2.97 12/07/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730045
Principal investigator 1 Novo Nordisk AS $25.06 12/07/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369825
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730017
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730027
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730035
Principal investigator 1 Novo Nordisk AS $1,000.00 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730053
Principal investigator 1 Novo Nordisk AS $2,957.62 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730063
Principal investigator 1 Novo Nordisk AS $2,330.10 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730073
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730315
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730325
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730335
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730345
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846921
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847159
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847167
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847177
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847187
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369805
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369815
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371259
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371269
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371279
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371289
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371298
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811382041
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811552655
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811552663
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811552673
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811552683
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811564195
Principal investigator 1 Novo Nordisk AS $99.80 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811564205
Principal investigator 1 Novo Nordisk AS $4,950.04 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825271
Principal investigator 1 Novo Nordisk AS $862.87 11/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838827
Principal investigator 1 Novo Nordisk AS $5,142.39 11/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649437
Principal investigator 1 Novo Nordisk AS $2.97 11/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846987
Principal investigator 1 Novo Nordisk AS $25.06 11/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369795
Principal investigator 1 Novo Nordisk AS $24.56 11/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825205
Principal investigator 1 Novo Nordisk AS $25.06 11/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811581749
Principal investigator 1 Novo Nordisk AS $25.06 11/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811581758
Principal investigator 1 Novo Nordisk AS $25.06 11/16/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730129
Principal investigator 1 Novo Nordisk AS $2.97 11/16/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371137
Principal investigator 1 Medtronic, Inc. $20,332.00 11/12/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP332 NGS No dispute reported 06/30/2026 801005873
Principal investigator 1 Medtronic, Inc. $10,713.07 11/12/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 801006437
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810729987
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810729997
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730007
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730089
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730099
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730109
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730119
Principal investigator 1 Novo Nordisk AS $2.97 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730239
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730249
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730259
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730269
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730277
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730285
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730295
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730305
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810733843
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846881
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846891
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846901
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846911
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846967
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846977
Principal investigator 1 Novo Nordisk AS $19.99 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847073
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847083
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847093
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847101
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847111
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847120
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847131
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847141
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847149
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810850015
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369699
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369709
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369717
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369727
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369735
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369745
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369755
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369765
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369775
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369785
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371107
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371117
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371127
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371213
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371223
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371233
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371241
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371249
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811382071
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811551855
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811551865
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811551875
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811551885
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811551895
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811551921
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811551951
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811551961
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811552599
Principal investigator 1 Novo Nordisk AS $34.93 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811552609
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811552619
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811552627
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811552637
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811552647
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811564175
Principal investigator 1 Novo Nordisk AS $32.50 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811564185
Principal investigator 1 Novo Nordisk AS $23.06 11/10/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810853695
Principal investigator 1 Novo Nordisk AS $904.00 11/10/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825203
Principal investigator 1 Medtronic, Inc. $420.00 11/08/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP332 NGS No dispute reported 06/30/2026 801005871
Principal investigator 1 Novo Nordisk AS $23.06 11/04/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810853685
Principal investigator 1 Medtronic, Inc. $34,881.00 11/03/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP332 NGS No dispute reported 06/30/2026 801005869
Principal investigator 1 Novo Nordisk AS $19.00 11/02/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825201
Principal investigator 1 Novo Nordisk AS $394.00 11/02/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825255
Principal investigator 1 Novo Nordisk AS $69.18 10/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730231
Principal investigator 1 Novo Nordisk AS $394.00 10/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336935
Principal investigator 1 Novo Nordisk AS $19.00 10/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336943
Principal investigator 1 Novo Nordisk AS $69.18 10/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811382061
Principal investigator 1 Novo Nordisk AS $1,063.12 10/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846927
Principal investigator 1 Novo Nordisk AS $2,823.77 10/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810853705
Principal investigator 1 Novo Nordisk AS $5.70 10/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068025
Principal investigator 1 Novo Nordisk AS $3.04 10/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068039
Principal investigator 1 Novo Nordisk AS $40.00 10/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339701
Principal investigator 1 Novo Nordisk AS $6,326.48 10/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649429
Principal investigator 1 Novo Nordisk AS $878.40 10/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785855
Principal investigator 1 Novo Nordisk AS $8.00 10/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787249
Principal investigator 1 Novo Nordisk AS $11.72 10/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787251
Principal investigator 1 Novo Nordisk AS $39.90 10/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787253
Principal investigator 1 Novo Nordisk AS $9.74 10/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787255
Principal investigator 1 Novo Nordisk AS $0.50 10/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825251
Principal investigator 1 Novo Nordisk AS $6.50 10/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825253
Principal investigator 1 Novo Nordisk AS $8,134.34 10/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825269
Principal investigator 1 Medtronic, Inc. $2,901.00 10/21/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 801002915
Principal investigator 1 Medtronic, Inc. $11,109.44 10/21/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP321 AHCL Pivotal Study No dispute reported 06/30/2026 801006435
Principal investigator 1 Medtronic, Inc. $834.70 10/21/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP304 HCL Outcomes Study No dispute reported 06/30/2026 801011031
Principal investigator 1 Novo Nordisk AS $69.18 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847063
Principal investigator 1 Novo Nordisk AS $100.00 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067985
Principal investigator 1 Novo Nordisk AS $100.00 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067999
Principal investigator 1 Novo Nordisk AS $100.00 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068013
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068355
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068365
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068379
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068391
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068405
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068421
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068433
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068447
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068649
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068661
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068673
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068687
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068701
Principal investigator 1 Novo Nordisk AS $20.00 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068807
Principal investigator 1 Novo Nordisk AS $20.00 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068821
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068833
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068847
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068861
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068873
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068887
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068899
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068911
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068925
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068937
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068951
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068965
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811077713
Principal investigator 1 Novo Nordisk AS $100.00 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336925
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337319
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337327
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337337
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337345
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337351
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337361
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337367
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337375
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337381
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339359
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339369
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339376
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339385
Principal investigator 1 Novo Nordisk AS $20.00 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339641
Principal investigator 1 Novo Nordisk AS $20.00 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339651
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339661
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339671
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339681
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339691
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785897
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785899
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785901
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785903
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785905
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785907
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785909
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785911
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785913
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785915
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785917
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785919
Principal investigator 1 Novo Nordisk AS $100.00 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785921
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811786949
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811786951
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811786953
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811786955
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811786957
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811786959
Principal investigator 1 Novo Nordisk AS $20.00 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787221
Principal investigator 1 Novo Nordisk AS $20.00 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787223
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787225
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787227
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787229
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787231
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787233
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787235
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787237
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787239
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787241
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787243
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787245
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787247
Principal investigator 1 Novo Nordisk AS $100.00 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825057
Principal investigator 1 Novo Nordisk AS $100.00 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825059
Principal investigator 1 Novo Nordisk AS $100.00 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825061
Principal investigator 1 Novo Nordisk AS $20.00 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825121
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825123
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825125
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825127
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825129
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825131
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825133
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825135
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825137
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825139
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825141
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825143
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825145
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825147
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825149
Principal investigator 1 Novo Nordisk AS $100.00 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825151
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825191
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825193
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825195
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825197
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825199
Principal investigator 1 Novo Nordisk AS $20.00 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825221
Principal investigator 1 Novo Nordisk AS $20.00 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825223
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825225
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825227
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825229
Principal investigator 1 Novo Nordisk AS $17.07 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825231
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825233
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825235
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825237
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825239
Principal investigator 1 Novo Nordisk AS $14.97 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825241
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825243
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825245
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825247
Principal investigator 1 Novo Nordisk AS $32.50 10/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825249
Principal investigator 1 Medtronic, Inc. $798.00 10/11/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP332 NGS No dispute reported 06/30/2026 801005881
Principal investigator 1 Novo Nordisk AS $23.06 10/08/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811581699
Principal investigator 1 Medtronic, Inc. $6,236.00 10/05/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP332 NGS No dispute reported 06/30/2026 801005879
Principal investigator 1 Novo Nordisk AS $23.06 09/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398365
Principal investigator 1 Novo Nordisk AS $69.18 09/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811551845
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811339867
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811339877
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811339965
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811339975
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811339985
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811340921
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811340931
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811340941
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351225
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351235
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351245
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351255
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351265
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351275
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351285
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351295
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351305
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351315
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351325
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351335
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351345
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351355
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351401
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351411
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351421
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351431
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351437
Principal investigator 1 Novo Nordisk AS $180.00 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351447
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351457
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649387
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649391
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649395
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649401
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649407
Principal investigator 1 Novo Nordisk AS $180.00 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649411
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649897
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649903
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649909
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649914
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649919
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649925
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649931
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649937
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649943
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649951
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650021
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650027
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650033
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650039
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650043
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650049
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650295
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650301
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650307
Principal investigator 1 Novo Nordisk AS $180.00 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650313
Principal investigator 1 Novo Nordisk AS $180.00 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650319
Principal investigator 1 Novo Nordisk AS $180.00 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650325
Principal investigator 1 Novo Nordisk AS $180.00 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650331
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650337
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650343
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839613
Principal investigator 1 Novo Nordisk AS $180.00 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839615
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839631
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839633
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839635
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839637
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839657
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839659
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839661
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839663
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839665
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839667
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839669
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839671
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839673
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839675
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839691
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839693
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839695
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839697
Principal investigator 1 Novo Nordisk AS $180.00 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839699
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839701
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867625
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867627
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867629
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867631
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867647
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867649
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867651
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867653
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867655
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867657
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867683
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867685
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867723
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867725
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867727
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867729
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867731
Principal investigator 1 Novo Nordisk AS $51.21 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867745
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867747
Principal investigator 1 Novo Nordisk AS $44.91 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867749
Principal investigator 1 Novo Nordisk AS $180.00 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867751
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867753
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867755
Principal investigator 1 Novo Nordisk AS $19.50 09/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867757
Principal investigator 1 Novo Nordisk AS $3,596.92 09/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810737223
Principal investigator 1 Novo Nordisk AS $2,362.50 09/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730159
Principal investigator 1 Novo Nordisk AS $2,948.40 09/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730167
Principal investigator 1 Novo Nordisk AS $100.00 09/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787263
Principal investigator 1 Novo Nordisk AS $3,383.47 09/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787265
Principal investigator 1 Novo Nordisk AS $3,757.53 09/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839617
Principal investigator 1 Medtronic, Inc. $56.00 09/22/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 801002913
Principal investigator 1 Novo Nordisk AS $240.00 09/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810729967
Principal investigator 1 Novo Nordisk AS $144.00 09/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846861
Principal investigator 1 Novo Nordisk AS $36.00 09/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846947
Principal investigator 1 Novo Nordisk AS $159.92 09/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846957
Principal investigator 1 Novo Nordisk AS $26.00 09/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369497
Principal investigator 1 Novo Nordisk AS $36.00 09/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369853
Principal investigator 1 Novo Nordisk AS $36.00 09/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811382031
Principal investigator 1 Novo Nordisk AS $20.40 09/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811551913
Principal investigator 1 Medtronic, Inc. $6,205.00 09/15/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CIP331 Smart Pen No dispute reported 06/30/2026 801002911
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810729947
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810729957
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730081
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730195
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730205
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730213
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810733853
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846835
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846845
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846855
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846937
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847023
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847033
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847043
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369487
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371184
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371193
Principal investigator 1 Novo Nordisk AS $23.06 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398355
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811551835
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811551905
Principal investigator 1 Novo Nordisk AS $450.00 09/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811551941
Principal investigator 1 Novo Nordisk AS $23.06 09/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810737187
Principal investigator 1 Novo Nordisk AS $330.00 09/06/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068327
Principal investigator 1 Novo Nordisk AS $990.00 09/06/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337295
Principal investigator 1 Novo Nordisk AS $24.56 09/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811761129
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810737111
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810737121
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810737159
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810737167
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810737195
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810737205
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810853621
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810853629
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810853639
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810853649
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810853659
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810853665
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398229
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398239
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398249
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398259
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398285
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398295
Principal investigator 1 Novo Nordisk AS $150.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398371
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398381
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811424135
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811581131
Principal investigator 1 Novo Nordisk AS $15.00 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811581141
Principal investigator 1 Novo Nordisk AS $1,575.00 08/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810729977
Principal investigator 1 Novo Nordisk AS $100.00 08/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337311
Principal investigator 1 Novo Nordisk AS $1,965.60 08/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371203
Principal investigator 1 Novo Nordisk AS $745.88 08/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811581161
Principal investigator 1 Novo Nordisk AS $150.00 08/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811581171
Principal investigator 1 Novo Nordisk AS $23.06 08/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811581739
Principal investigator 1 Novo Nordisk AS $10,193.10 08/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649423
Principal investigator 1 Novo Nordisk AS $4,174.89 08/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785895
Principal investigator 1 Novo Nordisk AS $23.06 08/23/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811581729
Principal investigator 1 Novo Nordisk AS $5.94 08/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067625
Principal investigator 1 Novo Nordisk AS $904.00 08/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067639
Principal investigator 1 Novo Nordisk AS $8.00 08/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067653
Principal investigator 1 Novo Nordisk AS $9.74 08/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067667
Principal investigator 1 Novo Nordisk AS $40.00 08/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067681
Principal investigator 1 Novo Nordisk AS $11.72 08/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336773
Principal investigator 1 Novo Nordisk AS $325.80 08/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785593
Principal investigator 1 Novo Nordisk AS $439.20 08/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785595
Principal investigator 1 Novo Nordisk AS $5.30 08/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785597
Principal investigator 1 Novo Nordisk AS $3.04 08/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785599
Principal investigator 1 Novo Nordisk AS $6.50 08/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785601
Principal investigator 1 Novo Nordisk AS $0.10 08/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787293
Principal investigator 1 Novo Nordisk AS $0.50 08/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825007
Principal investigator 1 Novo Nordisk AS $39.90 08/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825009
Principal investigator 1 Novo Nordisk AS $23.06 08/11/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810853675
Principal investigator 1 Novo Nordisk AS $23.06 08/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811581719
Principal investigator 1 Novo Nordisk AS $13.98 08/03/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069217
Principal investigator 1 Novo Nordisk AS $13.98 08/03/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069231
Principal investigator 1 Novo Nordisk AS $3.30 08/03/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340073
Principal investigator 1 Novo Nordisk AS $3.30 08/03/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787287
Principal investigator 1 Novo Nordisk AS $3.30 08/03/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787289
Principal investigator 1 Novo Nordisk AS $3.30 08/03/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787291
Principal investigator 1 Novo Nordisk AS $3.30 08/03/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825295
Principal investigator 1 Novo Nordisk AS $17.61 07/30/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049321
Principal investigator 1 Novo Nordisk AS $17.61 07/30/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049707
Principal investigator 1 Novo Nordisk AS $17.61 07/30/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049719
Principal investigator 1 Novo Nordisk AS $17.61 07/30/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811642601
Principal investigator 1 Novo Nordisk AS $17.61 07/30/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811642605
Principal investigator 1 Novo Nordisk AS $17.61 07/30/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811761127
Principal investigator 1 Novo Nordisk AS $17.61 07/30/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811761649
Principal investigator 1 Novo Nordisk AS $3,250.12 07/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337303
Principal investigator 1 Novo Nordisk AS $1,800.01 07/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811581151
Principal investigator 1 Novo Nordisk AS $694.12 07/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811642357
Principal investigator 1 Novo Nordisk AS $3,745.17 07/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649417
Principal investigator 1 Novo Nordisk AS $1,965.60 07/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846871
Principal investigator 1 Novo Nordisk AS $1,575.00 07/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369689
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068285
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068299
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068311
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068529
Principal investigator 1 Novo Nordisk AS $200.00 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068542
Principal investigator 1 Novo Nordisk AS $200.00 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068555
Principal investigator 1 Novo Nordisk AS $200.00 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068569
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069163
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069177
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069191
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069203
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337211
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337217
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337227
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337235
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337243
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337253
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337261
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337269
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339297
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339307
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339317
Principal investigator 1 Novo Nordisk AS $200.00 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339327
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339997
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340006
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340015
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340025
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340035
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340043
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340053
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340063
Principal investigator 1 Novo Nordisk AS $23.06 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398345
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785877
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785879
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785881
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785883
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785885
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785887
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785889
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785891
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811786937
Principal investigator 1 Novo Nordisk AS $200.00 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811786939
Principal investigator 1 Novo Nordisk AS $200.00 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811786941
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787273
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787275
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787277
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787279
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787281
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787283
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787285
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825099
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825101
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825103
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825105
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825107
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825109
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825111
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825113
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825115
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825117
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825177
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825179
Principal investigator 1 Novo Nordisk AS $200.00 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825181
Principal investigator 1 Novo Nordisk AS $28.45 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825285
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825287
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825289
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825291
Principal investigator 1 Novo Nordisk AS $24.95 07/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825293
Principal investigator 1 Medtronic, Inc. $793.50 07/07/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP304 HCL Outcomes Study No dispute reported 06/30/2026 801011029
Principal investigator 1 Novo Nordisk AS $2.75 07/06/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371167
Principal investigator 1 Novo Nordisk AS $23.06 07/06/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371177
Principal investigator 1 Novo Nordisk AS $23.06 06/30/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398335
Principal investigator 1 Novo Nordisk AS $7.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067597
Principal investigator 1 Novo Nordisk AS $7.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067611
Principal investigator 1 Novo Nordisk AS $300.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067855
Principal investigator 1 Novo Nordisk AS $300.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067865
Principal investigator 1 Novo Nordisk AS $300.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067878
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067891
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067905
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067919
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067933
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067943
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067957
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067971
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068191
Principal investigator 1 Novo Nordisk AS $7.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068205
Principal investigator 1 Novo Nordisk AS $7.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068219
Principal investigator 1 Novo Nordisk AS $7.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068233
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068243
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068257
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068271
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068461
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068475
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068489
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068503
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068517
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069109
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069123
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069137
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069151
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069321
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069335
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069349
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069363
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069377
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069391
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069402
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069415
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069429
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069443
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069457
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069469
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069483
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069497
Principal investigator 1 Novo Nordisk AS $300.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336763
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336831
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336839
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336849
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336859
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336869
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336873
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336881
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336889
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336897
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336907
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336917
Principal investigator 1 Novo Nordisk AS $7.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337005
Principal investigator 1 Novo Nordisk AS $7.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337013
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337175
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337183
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337191
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337201
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337401
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337409
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337417
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337425
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337433
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337441
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337449
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337457
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339289
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339767
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339777
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339787
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339797
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339807
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340265
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340275
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340285
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340295
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340303
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340313
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340323
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340333
Principal investigator 1 Novo Nordisk AS $2.75 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811382051
Principal investigator 1 Novo Nordisk AS $23.06 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811551931
Principal investigator 1 Novo Nordisk AS $7.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785591
Principal investigator 1 Novo Nordisk AS $300.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785653
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785655
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785657
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785659
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785661
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785663
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785665
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785667
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785669
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785671
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785673
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785851
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785853
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785871
Principal investigator 1 Novo Nordisk AS $7.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785873
Principal investigator 1 Novo Nordisk AS $7.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785875
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811786925
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811786927
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811786929
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811786931
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811786933
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811786935
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787267
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787269
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787271
Principal investigator 1 Novo Nordisk AS $300.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787311
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787313
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787315
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787343
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787345
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787347
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787349
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787351
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787353
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787355
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787357
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787359
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787361
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787363
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787365
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811790719
Principal investigator 1 Novo Nordisk AS $7.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825003
Principal investigator 1 Novo Nordisk AS $7.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825005
Principal investigator 1 Novo Nordisk AS $300.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825027
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825029
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825031
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825033
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825035
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825037
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825039
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825041
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825043
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825045
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825047
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825049
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825051
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825053
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825055
Principal investigator 1 Novo Nordisk AS $7.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825089
Principal investigator 1 Novo Nordisk AS $7.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825091
Principal investigator 1 Novo Nordisk AS $7.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825093
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825095
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825097
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825161
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825163
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825165
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825167
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825169
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825171
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825173
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825175
Principal investigator 1 Novo Nordisk AS $7.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825277
Principal investigator 1 Novo Nordisk AS $7.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825279
Principal investigator 1 Novo Nordisk AS $7.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825281
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825283
Principal investigator 1 Novo Nordisk AS $10.60 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825307
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825309
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825311
Principal investigator 1 Novo Nordisk AS $22.76 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825313
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825315
Principal investigator 1 Novo Nordisk AS $19.96 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825317
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825319
Principal investigator 1 Novo Nordisk AS $13.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825321
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825323
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825325
Principal investigator 1 Novo Nordisk AS $6.00 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825327
Principal investigator 1 Novo Nordisk AS $2,795.00 06/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067495
Principal investigator 1 Novo Nordisk AS $452.00 06/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067586
Principal investigator 1 Novo Nordisk AS $1,000.00 06/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340343
Principal investigator 1 Novo Nordisk AS $4,797.03 06/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351483
Principal investigator 1 Novo Nordisk AS $1,220.08 06/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811403579
Principal investigator 1 Novo Nordisk AS $4,587.75 06/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825329
Principal investigator 1 Novo Nordisk AS $219.60 06/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067561
Principal investigator 1 Novo Nordisk AS $2.65 06/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067571
Principal investigator 1 Novo Nordisk AS $3.25 06/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069311
Principal investigator 1 Novo Nordisk AS $162.90 06/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336747
Principal investigator 1 Novo Nordisk AS $1.52 06/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336753
Principal investigator 1 Novo Nordisk AS $19.95 06/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340235
Principal investigator 1 Novo Nordisk AS $20.00 06/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340245
Principal investigator 1 Novo Nordisk AS $0.10 06/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340255
Principal investigator 1 Novo Nordisk AS $4.87 06/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787307
Principal investigator 1 Novo Nordisk AS $2.97 06/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787309
Principal investigator 1 Novo Nordisk AS $452.00 06/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811824997
Principal investigator 1 Novo Nordisk AS $4.00 06/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811824999
Principal investigator 1 Novo Nordisk AS $5.86 06/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825001
Principal investigator 1 Novo Nordisk AS $0.25 06/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825305
Principal investigator 1 Novo Nordisk AS $23.06 06/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730187
Principal investigator 1 Novo Nordisk AS $23.06 06/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810737177
Principal investigator 1 Novo Nordisk AS $2.75 06/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847013
Principal investigator 1 Novo Nordisk AS $2.75 06/21/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847007
Principal investigator 1 Novo Nordisk AS $23.06 06/21/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371157
Principal investigator 1 Novo Nordisk AS $23.06 06/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398325
Principal investigator 1 Novo Nordisk AS $162.90 06/10/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337394
Principal investigator 1 Novo Nordisk AS $219.60 06/10/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340225
Principal investigator 1 Novo Nordisk AS $23.06 06/08/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810730177
Principal investigator 1 Novo Nordisk AS $2.75 06/08/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846825
Principal investigator 1 Eli Lilly and Company $48.21 05/31/2021 Non-covered Recipient Entity
PIEDMONT MEDICAL RESEARCH ASSOCIATES INC
A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN STUDY PARTICIPANTS WITH TYPE 1 DIABETES MELLITUS PREVIOUSLY TREATED WITH MULTIPLE DAILY INJECTION THERAPY No dispute reported 06/30/2026 819466697
Principal investigator 1 Novo Nordisk AS $2.75 05/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846815
Principal investigator 1 Novo Nordisk AS $23.06 05/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811369478
Principal investigator 1 Medtronic, Inc. $1,383.80 05/26/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP304 HCL Outcomes Study No dispute reported 06/30/2026 801011027
Principal investigator 1 Novo Nordisk AS $1,417.50 05/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810853209
Principal investigator 1 Novo Nordisk AS $23.06 05/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811581709
Principal investigator 1 Novo Nordisk AS $2,710.13 05/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811587069
Principal investigator 1 Novo Nordisk AS $100.00 05/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650355
Principal investigator 1 Novo Nordisk AS $4,303.13 05/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867803
Principal investigator 1 Novo Nordisk AS $23.06 05/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398315
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067507
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067520
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067533
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067547
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069299
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336727
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336737
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337387
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340148
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340159
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785923
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787301
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787303
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787305
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811824995
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825153
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825155
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825157
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825159
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825301
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825303
Principal investigator 1 Novo Nordisk AS $2.75 05/17/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810846805
Principal investigator 1 Novo Nordisk AS $23.06 05/17/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811564169
Principal investigator 1 Novo Nordisk AS $0.20 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067721
Principal investigator 1 Novo Nordisk AS $325.80 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067735
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067747
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067761
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067773
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067787
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067801
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067815
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067829
Principal investigator 1 Novo Nordisk AS $1.95 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067841
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068623
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068637
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068757
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068769
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068781
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068793
Principal investigator 1 Novo Nordisk AS $5.94 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336793
Principal investigator 1 Novo Nordisk AS $904.00 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336803
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336813
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336823
Principal investigator 1 Novo Nordisk AS $1.95 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337279
Principal investigator 1 Novo Nordisk AS $1.95 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811337287
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339349
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339445
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339455
Principal investigator 1 Novo Nordisk AS $439.20 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785643
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785645
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785647
Principal investigator 1 Novo Nordisk AS $1.95 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785649
Principal investigator 1 Novo Nordisk AS $1.95 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785651
Principal investigator 1 Novo Nordisk AS $1.95 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785893
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787215
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787217
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787219
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825017
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825019
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825021
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825023
Principal investigator 1 Novo Nordisk AS $1.95 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825025
Principal investigator 1 Novo Nordisk AS $1.95 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825119
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825183
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825185
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825187
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825189
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825207
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825209
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825211
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825213
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825215
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825217
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825219
Principal investigator 1 Novo Nordisk AS $23.06 05/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398305
Principal investigator 1 Novo Nordisk AS $23.06 05/07/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811581121
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067695
Principal investigator 1 Novo Nordisk AS $9.74 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811067709
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068583
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068597
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811068609
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069243
Principal investigator 1 Novo Nordisk AS $5.30 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069257
Principal investigator 1 Novo Nordisk AS $11.72 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069271
Principal investigator 1 Novo Nordisk AS $0.50 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811069285
Principal investigator 1 Novo Nordisk AS $40.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811336783
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811339339
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340083
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340093
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340101
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340109
Principal investigator 1 Novo Nordisk AS $3.04 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340119
Principal investigator 1 Novo Nordisk AS $39.90 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340129
Principal investigator 1 Novo Nordisk AS $6.50 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811340139
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785639
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811785641
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811786943
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811786945
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811786947
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787295
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787297
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811787299
Principal investigator 1 Novo Nordisk AS $3.01 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825011
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825013
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825015
Principal investigator 1 Novo Nordisk AS $3.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825297
Principal investigator 1 Novo Nordisk AS $8.00 05/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4480 No dispute reported 06/30/2026 811825299
Principal investigator 1 Medtronic, Inc. $1,822.10 05/04/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP304 HCL Outcomes Study No dispute reported 06/30/2026 801011025
Principal investigator 1 Eli Lilly and Company $47.50 04/30/2021 Non-covered Recipient Entity
PARAMOUNT MEDICAL RESEARCH AND CONSULTING
A PHASE 2, PARALLEL, COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN INSULIN NAIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 819462395
Principal investigator 1 Eli Lilly and Company $48.21 04/30/2021 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN STUDY PARTICIPANTS WITH TYPE 1 DIABETES MELLITUS PREVIOUSLY TREATED WITH MULTIPLE DAILY INJECTION THERAPY No dispute reported 06/30/2026 819466981
Principal investigator 1 Eli Lilly and Company $9,725.00 04/26/2021 Non-covered Recipient Entity
WEILL MEDICAL COLLEGE
A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN STUDY PARTICIPANTS WITH TYPE 1 DIABETES MELLITUS PREVIOUSLY TREATED WITH MULTIPLE DAILY INJECTION THERAPY No dispute reported 06/30/2026 819470623
Principal investigator 1 Novo Nordisk AS $2,228.62 04/23/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838835
Principal investigator 1 Novo Nordisk AS $1,000.00 04/23/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838979
Principal investigator 1 Novo Nordisk AS $1,063.12 04/23/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810847217
Principal investigator 1 Novo Nordisk AS $3,536.16 04/23/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811587049
Principal investigator 1 Novo Nordisk AS $3,000.00 04/23/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811761651
Principal investigator 1 Novo Nordisk AS $2,845.13 04/23/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867799
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811339927
Principal investigator 1 Novo Nordisk AS $200.00 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811339937
Principal investigator 1 Novo Nordisk AS $200.00 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811339945
Principal investigator 1 Novo Nordisk AS $200.00 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811339955
Principal investigator 1 Novo Nordisk AS $24.00 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811341077
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811341087
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351191
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351201
Principal investigator 1 Novo Nordisk AS $200.00 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351207
Principal investigator 1 Novo Nordisk AS $200.00 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351217
Principal investigator 1 Novo Nordisk AS $24.00 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351383
Principal investigator 1 Novo Nordisk AS $24.00 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351391
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649873
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649879
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649885
Principal investigator 1 Novo Nordisk AS $200.00 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649891
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650015
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839619
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839621
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839623
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839625
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839627
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839629
Principal investigator 1 Novo Nordisk AS $200.00 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839655
Principal investigator 1 Novo Nordisk AS $24.00 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839685
Principal investigator 1 Novo Nordisk AS $24.00 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839687
Principal investigator 1 Novo Nordisk AS $24.00 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839689
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867637
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867639
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867641
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867643
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867645
Principal investigator 1 Novo Nordisk AS $24.00 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867677
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867679
Principal investigator 1 Novo Nordisk AS $29.94 04/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867681
Principal investigator 1 Novo Nordisk AS $23.06 04/09/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811581113
Principal investigator 1 Novo Nordisk AS $23.06 04/07/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810737101
Principal investigator 1 Novo Nordisk AS $23.06 04/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811581105
Principal investigator 1 Novo Nordisk AS $23.06 03/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398219
Principal investigator 1 Novo Nordisk AS $3,919.50 03/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811340951
Principal investigator 1 Novo Nordisk AS $250.00 03/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371345
Principal investigator 1 Novo Nordisk AS $111.65 03/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811403531
Principal investigator 1 Novo Nordisk AS $250.00 03/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811552721
Principal investigator 1 Abbott Laboratories $64,000.00 03/23/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Pilot Study to observe smartphone meal logging and insulin administration methods and motivations of people with type 2 diabetes No dispute reported 06/30/2026 827579061
Principal investigator 1 Novo Nordisk AS $8.58 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811339817
Principal investigator 1 Novo Nordisk AS $658.80 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811339827
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811339837
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811339847
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811339857
Principal investigator 1 Novo Nordisk AS $4.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811339907
Principal investigator 1 Novo Nordisk AS $59.85 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811339917
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811340961
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811340971
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811340981
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811340991
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811341001
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811341007
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811341017
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811341027
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811341037
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811341047
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811341057
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811341067
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351365
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811351375
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649233
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649237
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649243
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649249
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649345
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649349
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649355
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649361
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649365
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649371
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649377
Principal investigator 1 Novo Nordisk AS $33.00 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649381
Principal investigator 1 Novo Nordisk AS $14.61 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649867
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649967
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649973
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649979
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649985
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649991
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649997
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650003
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650009
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650055
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650061
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650067
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811650074
Principal investigator 1 Novo Nordisk AS $4.53 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839599
Principal investigator 1 Novo Nordisk AS $1,782.00 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839601
Principal investigator 1 Novo Nordisk AS $3.66 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839603
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839605
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839607
Principal investigator 1 Novo Nordisk AS $7.95 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839609
Principal investigator 1 Novo Nordisk AS $12.00 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839611
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839643
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839645
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839647
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839649
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839651
Principal investigator 1 Novo Nordisk AS $0.30 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839653
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839677
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839679
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839681
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839683
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867571
Principal investigator 1 Novo Nordisk AS $488.70 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867573
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867575
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867577
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867615
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867617
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867619
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867621
Principal investigator 1 Novo Nordisk AS $4.53 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867623
Principal investigator 1 Novo Nordisk AS $108.00 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867633
Principal investigator 1 Novo Nordisk AS $9.75 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867635
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867661
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867663
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867665
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867667
Principal investigator 1 Novo Nordisk AS $60.00 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867669
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867671
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867673
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867675
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867733
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867735
Principal investigator 1 Novo Nordisk AS $2.65 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867737
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867739
Principal investigator 1 Novo Nordisk AS $14.97 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867741
Principal investigator 1 Novo Nordisk AS $1.50 03/18/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867743
Principal investigator 1 Medtronic, Inc. $1,455.40 03/17/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP304 HCL Outcomes Study No dispute reported 06/30/2026 801011023
Principal investigator 1 Novo Nordisk AS $23.06 03/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811424125
Principal investigator 1 Medtronic, Inc. $742.30 03/10/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP304 HCL Outcomes Study No dispute reported 06/30/2026 801011021
Principal investigator 1 Novo Nordisk AS $23.06 03/10/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398199
Principal investigator 1 Novo Nordisk AS $23.06 03/10/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398209
Principal investigator 1 Novo Nordisk AS $23.06 02/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810737149
Principal investigator 1 Novo Nordisk AS $130.00 02/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810853953
Principal investigator 1 Novo Nordisk AS $250.00 02/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810853963
Principal investigator 1 Novo Nordisk AS $2,351.83 02/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398599
Principal investigator 1 Novo Nordisk AS $3,150.00 02/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810850025
Principal investigator 1 Novo Nordisk AS $3,931.20 02/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811383289
Principal investigator 1 Novo Nordisk AS $23.06 02/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398275
Principal investigator 1 Medtronic, Inc. $520.70 02/17/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP304 HCL Outcomes Study No dispute reported 06/30/2026 801011019
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838809
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838819
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838845
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838855
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838865
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838873
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838883
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838893
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838903
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838913
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838919
Principal investigator 1 Novo Nordisk AS $1.95 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838929
Principal investigator 1 Novo Nordisk AS $1.95 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838939
Principal investigator 1 Novo Nordisk AS $1.95 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838949
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838959
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 810838969
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049223
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049237
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049251
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049265
Principal investigator 1 Novo Nordisk AS $44.46 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049279
Principal investigator 1 Novo Nordisk AS $9.75 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049293
Principal investigator 1 Novo Nordisk AS $14.61 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049307
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049335
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049349
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049597
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049613
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049625
Principal investigator 1 Novo Nordisk AS $28.47 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049639
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049653
Principal investigator 1 Novo Nordisk AS $60.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049667
Principal investigator 1 Novo Nordisk AS $1.95 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049679
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811049693
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811642333
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811642339
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811642345
Principal investigator 1 Novo Nordisk AS $166.14 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811642351
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811642361
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811642577
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811642583
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811642589
Principal investigator 1 Novo Nordisk AS $1.95 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811642595
Principal investigator 1 Novo Nordisk AS $12.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811644859
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811644865
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811647213
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811761119
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811761121
Principal investigator 1 Novo Nordisk AS $7.02 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811761123
Principal investigator 1 Novo Nordisk AS $59.85 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811761125
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811761131
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811761133
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811761135
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811761137
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811761639
Principal investigator 1 Novo Nordisk AS $4.99 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811761641
Principal investigator 1 Novo Nordisk AS $3.00 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811761643
Principal investigator 1 Novo Nordisk AS $1.95 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811761645
Principal investigator 1 Novo Nordisk AS $1.95 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811761647
Principal investigator 1 Novo Nordisk AS $7.95 02/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4481 No dispute reported 06/30/2026 811763423
Principal investigator 1 Novo Nordisk AS $594.00 02/08/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649961
Principal investigator 1 Novo Nordisk AS $41.06 02/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810737139
Principal investigator 1 Novo Nordisk AS $0.20 02/04/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811649955
Principal investigator 1 Novo Nordisk AS $162.90 02/04/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839639
Principal investigator 1 Novo Nordisk AS $219.60 02/04/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811839641
Principal investigator 1 Novo Nordisk AS $2.86 02/04/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4477 No dispute reported 06/30/2026 811867659
Principal investigator 1 Eli Lilly and Company $704.88 01/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
A PHASE 2, PARALLEL, COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN INSULIN NAIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 819468185
Principal investigator 1 Novo Nordisk AS $6.65 01/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 810729937
Principal investigator 1 Novo Nordisk AS $2,362.50 01/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371307
Principal investigator 1 Novo Nordisk AS $2,948.40 01/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 811371317
Principal investigator 1 Novo Nordisk AS $7.59 01/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810737241
Principal investigator 1 Novo Nordisk AS $100.00 01/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 810737249
Principal investigator 1 Novo Nordisk AS $2,713.51 01/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 811398269
Principal investigator 1 Medtronic, Inc. $1,291.65 01/20/2021 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP304 HCL Outcomes Study No dispute reported 06/30/2026 801011017
Principal investigator 1 Medtronic, Inc. $26,015.32 01/20/2021 Non-covered Recipient Entity
Texas Diabetes And Endocrinology P.A.
CEP304 HCL Outcomes Study No dispute reported 06/30/2026 801017659
Principal investigator 1 Eli Lilly and Company $26,232.21 01/15/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN STUDY PARTICIPANTS WITH TYPE 1 DIABETES MELLITUS PREVIOUSLY TREATED WITH MULTIPLE DAILY INJECTION THERAPY No dispute reported 06/30/2026 819467273
Principal investigator 1 AstraZeneca Pharmaceuticals LP $2,100.00 01/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacodynamic Effects of MEDI0382 in Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH) No dispute reported 06/30/2026 826452681
Principal investigator 1 Eli Lilly and Company $56,263.00 01/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
A PHASE 2, PARALLEL, COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN INSULIN NAIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 819468181
Principal investigator 1 Eli Lilly and Company $338,757.00 01/04/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN STUDY PARTICIPANTS WITH TYPE 1 DIABETES MELLITUS PREVIOUSLY TREATED WITH MULTIPLE DAILY INJECTION THERAPY No dispute reported 06/30/2026 819469603